Free Newsletter
Pharma's new aims explain reform support
Why is Big Pharma such a willing supporter of healthcare reform? The industry has transformed from a business aiming to sell pills to the masses to one that markets very expensive treatments to small groups of sick people--and that changes everything, Forbes' Matthew Herper contends. Report
More stories about healthcare reform
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: